Randomized, Single-Dose, Two-Way Crossover, Open-Label Study to Evaluate Pharmacokinetics of Bucretis Orodispersible Film 1.0 mg and Baraclude Tablet 1.0 mg in Healthy Thai Subjects under Fasting Conditions

Trial Profile

Randomized, Single-Dose, Two-Way Crossover, Open-Label Study to Evaluate Pharmacokinetics of Bucretis Orodispersible Film 1.0 mg and Baraclude Tablet 1.0 mg in Healthy Thai Subjects under Fasting Conditions

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 06 Jun 2017

At a glance

  • Drugs Entecavir (Primary)
  • Indications Hepatitis B
  • Focus Pharmacokinetics
  • Sponsors Abbott Healthcare Products
  • Most Recent Events

    • 06 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top